
Deepcell and InGel Therapeutics Announce Strategic Partnership to Advance Next-Generation Ocular Cell Therapies
Integration of Deepcell's REM-I will enable high-dimensional, label-free single cell analysis and sorting to accelerate InGel’s therapeutic development pipeline MENLO PARK, CA, UNITED STATES, September 15, 2025 /EINPresswire.com/ -- Deepcell, a …